WEED.TO - Canopy Growth Corporation
| Previous Close | 56.05 |
| Open | 56.51 |
| Bid | 56.21 x 0 |
| Ask | 56.21 x 0 |
| Day's Range | 56.02 - 57.12 |
| 52 Week Range | 31.81 - 76.68 |
| Volume | 1,309,043 |
| Avg. Volume | 2,215,279 |
| Market Cap | 19.416B |
| Beta (3Y Monthly) | 5.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.79 |
| Earnings Date | Jun 21, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 76.00 |
- MarketWatch•3 hours ago
Canopy Growth earnings: Can the world’s largest marijuana company keep growing like a weed?
After recreational marijuana sales were legalized last year, Canopy Growth Corp.’s pot sales jumped 360%. When the world’s largest pot company reports a fresher crop of results this week, that number may be less than 40%.
- Market Realist•6 hours ago
Canopy Updates on Europe, Australia, and Africa
Canopy Growth is making progress in the Australian market through its Spectrum Therapeutics brand, which caters to the demand for medical cannabis products. According to the company, the number of medical patients in the country has increased ten times in the last year.
- Market Realist•7 hours ago
What Would Legalization in New York State Mean for Cannabis?
New York has been on the fence about legalizing marijuana. In a series of tweets, New York City Mayor Bill De Blasio expressed strong support for legalizing cannabis the “RIGHT way.”
- Market Realist•7 hours ago
Canopy Growth Pens an Agreement with Procaps—Here Are the Details
On June 18, Canopy Growth (WEED) (CGC) announced another international development: it has entered into an agreement with Procaps in Colombia. According to Canopy Growth, Procaps is active across the world, exporting its products to over 50 international markets.
- Motley Fool•8 hours ago
Here's What's Behind June's Big Marijuana Stock Winner
Look beyond the obvious picks to find an impressive performance.
- Market Realist•9 hours ago
Canopy Growth’s 4Q Earnings: Profitability Expectations
On June 20, Canopy Growth (WEED) (CGC) is expected to report sales of 91.1 million Canadian dollars and a gross income of 24.4 million Canadian dollars. The company's margins are expected to compress.
- Market Realist•10 hours ago
Canopy Growth’s 4Q Earnings: What Can Investors Expect?
On June 20, Canopy Growth (WEED) (CGC) is scheduled to announce its fourth-quarter and fiscal 2019 earnings after the market closes. The company's guidance will likely set the tone for the cannabis industry's near-term expectations.
- MarketWatch•11 hours ago
Cannabis stocks mixed ahead of shareholder vote on Canopy/Acreage deal
Cannabis stocks are mixed, with market leader Canopy Growth Corp. gaining after it announced its latest growth moves ahead of Wednesday’s shareholder vote on its proposal to acquire Acreage Holdings.
- Benzinga•yesterday
Canopy Growth Announces Colombian Manufacturing Agreement For Oil-Based Products
Canopy said it will leverage Procaps’ encapsulation capacity. The Canopy subsidiary Spectrum Therapeutics has completed sales to patients in Chile and Brazil, the company said. In Australia, Spectrum received its first medical cannabis oil shipment in April, with sales commencing the following month.
- Investor's Business Daily•yesterday
Nasdaq Leads, Dow Jones Lags In Stock Market Rally; Lululemon Regains Entry
The tech-heavy Nasdaq led the way early Monday. Top growth stock Lululemon is regaining a buy point in today's stock market action.
- PR Newswire•yesterday
Canopy Growth Provides Update on International Operations and Activities
SMITHS FALLS, Ontario, June 17, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.
- Benzinga•yesterday
The Week Ahead In Cannabis: Canopy Earnings, CannaCon In Detroit And More
Last week was quite eventful for the cannabis industry, with Colorado reaching $1.0 billion in sales and Kroger Co (NYSE: KR ) announcing plans to start carrying CBD products. Here’s what you should keep ...
CNW Group•yesterdayCanopy Growth provides update on international operations and activities
SMITHS FALLS, ON , June 17, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.
- Market Realist•yesterday
Cannabis Sector Sentiment Weakened Last Week
The sentiment towards the cannabis sector weakened further last week, as major industry players ended in the negative territory. HEXO (HEXO), which released disappointing earnings on June 12, was one of the key reasons for the extension of the weakness in the sector last week.
- Investopedia•yesterday
Why 5 U.S. Cannabis Stocks Will Outperform Amid Federal Ban
Lower-valued American cannabis stocks are set to outperform their Canadian rivals as U.S. legal pot sales outpace those north of the border.
- Quartz•yesterday
The complete guide to the CBD boom
Everything you need to know about CBD and how it's taking over beauty, wellness, and just about every other product category.
- Motley Fool•2 days ago
The 5 Most Profitable Pot Stocks on the Planet
Most cannabis companies are losing money. These aren't.
- Motley Fool•2 days ago
Better Buy: Canopy Growth vs. Scotts Miracle-Gro
Which stock wins in a battle between the biggest cannabis producer by market cap and the biggest supplier to the cannabis industry?
- Motley Fool•2 days ago
4 of the 14 Most Widely Held Stocks on Investing App Robinhood Are Marijuana Stocks
Millennials love cannabis stocks. Unfortunately, two of their favorites could be duds.
- Motley Fool•3 days ago
The Best Cannabis Stock to Buy in June
This industry leader can help you earn a marijuana-fueled fortune.
- PR Newswire•4 days ago
Canopy Growth and Acreage Holdings Remind Shareholders to Vote FOR Canopy Growth's Plan to Acquire Acreage
Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders will benefit from Acreage's ability to achieve its growth strategy with an anticipated reduced cost of capital based on Canopy Growth affiliation. Canopy Growth shareholders will benefit from accelerated and turnkey access to the U.S. cannabis market upon the closing of the Transaction.
- Investopedia•5 days ago
Understanding Medical Cannabis vs. Recreational Cannabis Stocks
Medical marijuana and recreational marijuana are two high growth sectors in the cannabis industry. Learn about how the two differ, and how you can get into the market.
- Yahoo Finance•6 days ago
CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.
